- Home
- ADIL vs FRSX Comparison
ADIL vs FRSX Comparison
Compare ADIL & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- FRSX
- Stock Information
- Founded
- ADIL 2010
- FRSX N/A
- Country
- ADIL United States
- FRSX Israel
- Employees
- ADIL N/A
- FRSX N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- FRSX Computer Software: Prepackaged Software
- Sector
- ADIL Health Care
- FRSX Technology
- Exchange
- ADIL Nasdaq
- FRSX Nasdaq
- Market Cap
- ADIL 6.0M
- FRSX 7.0M
- IPO Year
- ADIL 2018
- FRSX 2017
- Fundamental
- Price
- ADIL $0.38
- FRSX $2.29
- Analyst Decision
- ADIL Strong Buy
- FRSX
- Analyst Count
- ADIL 1
- FRSX 0
- Target Price
- ADIL $8.00
- FRSX N/A
- AVG Volume (30 Days)
- ADIL 696.7K
- FRSX 42.8K
- Earning Date
- ADIL 08-13-2025
- FRSX 09-21-2025
- Dividend Yield
- ADIL N/A
- FRSX N/A
- EPS Growth
- ADIL N/A
- FRSX N/A
- EPS
- ADIL N/A
- FRSX N/A
- Revenue
- ADIL N/A
- FRSX $452,000.00
- Revenue This Year
- ADIL N/A
- FRSX N/A
- Revenue Next Year
- ADIL N/A
- FRSX N/A
- P/E Ratio
- ADIL N/A
- FRSX N/A
- Revenue Growth
- ADIL N/A
- FRSX N/A
- 52 Week Low
- ADIL $0.22
- FRSX $2.17
- 52 Week High
- ADIL $1.30
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- ADIL 43.92
- FRSX 35.49
- Support Level
- ADIL $0.37
- FRSX $2.32
- Resistance Level
- ADIL $0.40
- FRSX $2.56
- Average True Range (ATR)
- ADIL 0.02
- FRSX 0.21
- MACD
- ADIL 0.00
- FRSX 0.02
- Stochastic Oscillator
- ADIL 27.83
- FRSX 19.93
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.